Compile Data Set for Download or QSAR
Report error Found 58 Enz. Inhib. hit(s) with all data for entry = 10624
TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555221BDBM555221(US11339170, Example 42)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555220BDBM555220(US11339170, Example 41)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555223BDBM555223(US11339170, Example 44)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555222BDBM555222(US11339170, Example 43)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555225BDBM555225(US11339170, Example 46)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555224BDBM555224(US11339170, Example 45)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555227BDBM555227(US11339170, Example 48)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555226BDBM555226(US11339170, Example 47)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555229BDBM555229(US11339170, Example 50)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555228BDBM555228(US11339170, Example 49)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555230BDBM555230(US11339170, Example 51)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555233BDBM555233(US11339170, Example 68)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555235BDBM555235(US11339170, Example 70)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555234BDBM555234(US11339170, Example 69)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555203BDBM555203(US11339170, Example 26)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555202BDBM555202(US11339170, Example 25)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555207BDBM555207(US11339170, Example 28)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555209BDBM555209(US11339170, Example 30)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555211BDBM555211(US11339170, Example 32)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555210BDBM555210(US11339170, Example 31)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555213BDBM555213(US11339170, Example 34)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555212BDBM555212(US11339170, Example 33)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555214BDBM555214(US11339170, Example 35)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555217BDBM555217(US11339170, Example 38)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555216BDBM555216(US11339170, Example 37)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555219BDBM555219(US11339170, Example 40)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555218BDBM555218(US11339170, Example 39)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555237BDBM555237(US11339170, Example 72)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555236BDBM555236(US11339170, Example 71)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555186BDBM555186(US11339170, Example 10)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555185BDBM555185(US11339170, Example 9)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555188BDBM555188(US11339170, Example 12)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555187BDBM555187(US11339170, Example 11)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555191BDBM555191(US11339170, Example 14)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555189BDBM555189(US11339170, Example 13)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555193BDBM555193(US11339170, Example 16)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555192BDBM555192(US11339170, Example 15)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555195BDBM555195(US11339170, Example 18)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555194BDBM555194(US11339170, Example 17)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555197BDBM555197(US11339170, Example 23 | US11339170, Example 20)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555196BDBM555196(US11339170, Example 19)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555198BDBM555198(US11339170, Example 22 | US11339170, Example 21)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555198BDBM555198(US11339170, Example 22 | US11339170, Example 21)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555201BDBM555201(US11339170, Example 24)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555197BDBM555197(US11339170, Example 23 | US11339170, Example 20)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555177BDBM555177(US11339170, Example 2 | US11339170, Example 1)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555177BDBM555177(US11339170, Example 2 | US11339170, Example 1)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555180BDBM555180(US11339170, Example 4)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555179BDBM555179(US11339170, Example 3)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

TargetReplicase polyprotein 1ab(2019-nCoV)
Enanta Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 555184BDBM555184(US11339170, Example 8)
Affinity DataIC50: 100nMAssay Description:SARS-CoV-2 3C-like (3CL) protease fluorescence assay (FRET): Recombinant SARS-CoV-2 3CL-protease was expressed and purified. TAMRA-SITSAVLQSGFRKMIK-D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2022
Entry Details
US Patent

Displayed 1 to 50 (of 58 total ) | Next | Last >>
Jump to: